Common variable immunodeficiency revisited: Normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9

Clinical and Experimental Immunology

Volumn 175, Issue 3, 2014, Pages 439-448

  Taraldsrud, E ^a,b   Fevang, B ^a,b   Aukrust, P ^a,b   Beiske, K H ^a   Floisand Y ^a   Froland S ^a,b   Rollag, H ^b   Olweus, J ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Bone marrow; Common variable immunodeficiency; IFN ; Plasmacytoid dendritic cell; TLR 9

Indexed keywords

ALPHA INTERFERON; BIOLOGICAL MARKER; CD34 ANTIGEN; INTERLEUKIN 12; RESIQUIMOD; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ADULT; ARTICLE; BLOOD; BONE MARROW; CELL COUNT; CELL LEVEL; CELL LINE; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOREACTIVITY; MALE; MIDDLE AGED; MYELOID DENDRITIC CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BONE MARROW; COMMON VARIABLE IMMUNODEFICIENCY; IFN-Α; PLASMACYTOID DENDRITIC CELL; TLR-9;

ADULT; BLOOD CELL COUNT; BONE MARROW CELLS; CASE-CONTROL STUDIES; COMMON VARIABLE IMMUNODEFICIENCY; CYTOMEGALOVIRUS; DENDRITIC CELLS; FEMALE; HLA-DR ANTIGENS; HUMANS; IMIDAZOLES; INDUCIBLE T-CELL CO-STIMULATOR LIGAND; INTESTINE, SMALL; L-SELECTIN; LIGANDS; MALE; MIDDLE AGED; RECEPTORS, CCR7; SPLEEN; STEM CELLS; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9;

EID: 84893415662     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12239     Document Type: Article

References (49)

1. Al-Herz W, Bousfiha A, Casanova JL etal. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies expert committee for primary immunodeficiency. Front Immunol 2011; 2:54.
2. Aukrust P, Froland SS, Muller F. Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features. Clin Exp Immunol 1992; 89:211-216.
3. Resnick ES, Cunningham-Rundles C. The many faces of the clinical picture of common variable immune deficiency. Curr Opin Allergy Clin Immunol 2012; 12:595-601.
4. Mouillot G, Carmagnat M, Gerard L etal. B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease. J Clin Immunol 2010; 30:746-755.
5. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92:34-48.
6. Chapel H, Lucas M, Lee M etal. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008; 112:277-286.
7. Yong PF, Thaventhiran JE, Grimbacher B. 'A rose is a rose is a rose, ' but CVID is not CVID common variable immune deficiency (CVID), what do we know in 2011? Adv Immunol 2011; 111:47-107.
8. Kadowaki N, Ho S, Antonenko S etal. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J Exp Med 2001; 194:863-869.
9. Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003; 19:225-234.
10. Bayry J, Lacroix-Desmazes S, Kazatchkine MD etal. Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood 2004; 104:2441-2443.
11. Nourizadeh M, Aghamohammadi A, Moazzeni SM etal. Altered dendritic cell function in response to sera of common variable immunodeficiency patients. Inflamm Res 2007; 56:527-532.
12. Scott-Taylor TH, Green MR, Eren E, Webster AD. Monocyte-derived dendritic cell responses in common variable immunodeficiency. Clin Exp Immunol 2004; 138:484-490.
13. Scott-Taylor TH, Green MR, Raeiszadeh M, Workman S, Webster AD. Defective maturation of dendritic cells in common variable immunodeficiency. Clin Exp Immunol 2006; 145:420-427.
14. Cunningham-Rundles C, Radigan L. Deficient IL-12 and dendritic cell function in common variable immune deficiency. Clin Immunol 2005; 115:147-153.
15. Belz GT, Nutt SL. Transcriptional programming of the dendritic cell network. Nat Rev Immunol 2012; 12:101-113.
16. Olweus J, BitMansour A, Warnke R etal. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA 1997; 94:12551-12556.
17. Schreibelt G, Tel J, Sliepen KH etal. Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy. Cancer Immunol Immunother 2010; 59:1573-1582.
18. Kvale EO, Floisand Y, Lund-Johansen F etal. Plasmacytoid DCs regulate recall responses by rapid induction of IL-10 in memory T cells. Blood 2007; 109:3369-3376.
19. Kvale EO, Dalgaard J, Lund-Johansen F etal. CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection. Blood 2006; 107:2022-2029.
20. Krug A, Towarowski A, Britsch S etal. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol 2001; 31:3026-3037.
21. Farkas L, Kvale EO, Johansen FE, Jahnsen FL, Lund-Johansen F. Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides. J Allergy Clin Immunol 2004; 114:436-443.
22. Swiecki M, Colonna M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev 2010; 234:142-162.
23. Martinez-Pomar N, Raga S, Ferrer J etal. Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene. Clin Exp Immunol 2006; 144:233-238.
24. Viallard JF, Camou F, Andre M etal. Altered dendritic cell distribution in patients with common variable immunodeficiency. Arthritis Res Ther 2005; 7:R1052-R1055.
25. Yong PF, Workman S, Wahid F, Exley A, Webster AD, Ibrahim MA. Selective deficits in blood dendritic cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia but not specific polysaccharide antibody deficiency. Clin Immunol 2008; 127:34-42.
26. Cunningham-Rundles C, Radigan L, Knight AK, Zhang L, Bauer L, Nakazawa A. TLR9 activation is defective in common variable immune deficiency. J Immunol 2006; 176:1978-1987.
27. Yu JE, Knight AK, Radigan L etal. Toll-like receptor 7 and 9 defects in common variable immunodeficiency. J Allergy Clin Immunol 2009; 124:349-356. 356.
28. Malphettes M, Gerard L, Carmagnat M etal. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis 2009; 49:1329-1338.
29. Olweus J, Thompson PA, Lund-Johansen F. Granulocytic and monocytic differentiation of CD34hi cells is associated with distinct changes in the expression of the PU.1-regulated molecules, CD64 and macrophage colony-stimulating factor receptor. Blood 1996; 88:3741-3754.
30. Dzionek A, Fuchs A, Schmidt P etal. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000; 165:6037-6046.
31. Ito T, Kanzler H, Duramad O, Cao W, Liu YJ. Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 2006; 107:2423-2431.
32. Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 2000; 1:305-310.
33. Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 2001; 31:3388-3393.
34. Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL. Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 2001; 159:237-243.
35. Raki M, Beitnes AC, Lundin KE, Jahnsen J, Jahnsen FL, Sollid LM. Plasmacytoid dendritic cells are scarcely represented in the human gut mucosa and are not recruited to the celiac lesion. Mucosal Immunol 2013; 6:985-992.
36. Velasquez-Lopera MM, Correa LA, Garcia LF. Human spleen contains different subsets of dendritic cells and regulatory T lymphocytes. Clin Exp Immunol 2008; 154:107-114.
37. Trujillo CM, Muskus C, Arango J, Patino PJ, Montoya CJ. Quantitative and functional evaluation of innate immune responses in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol 2011; 21:207-215.
38. Donaghy H, Pozniak A, Gazzard B etal. Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 2001; 98:2574-2576.
39. Grimaldi D, Louis S, Pene F etal. Profound and persistent decrease of circulating dendritic cells is associated with ICU-acquired infection in patients with septic shock. Intens Care Med 2011; 37:1438-1446.
40. Lichtner M, Mastroianni CM, Rossi R etal. Severe and persistent depletion of circulating plasmacytoid dendritic cells in patients with 2009 pandemic H1N1 infection. PLOS ONE 2011; 6:e19872.
41. Wertheimer AM, Bakke A, Rosen HR. Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. Hepatology 2004; 40:335-345.
42. Lichtner M, Rossi R, Mengoni F etal. Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: correlation with clinical outcome and treatment response. Clin Exp Immunol 2006; 143:329-337.
43. Blomberg S, Eloranta ML, Magnusson M, Alm GV, Ronnblom L. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum 2003; 48:2524-2532.
44. Vogelsang P, Brun JG, Oijordsbakken G, Skarstein K, Jonsson R, Appel S. Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary Sjogren's syndrome. Ann Rheum Dis 2010; 69:1235-1238.
45. Jongbloed SL, Lebre MC, Fraser AR etal. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthritis Res Ther 2006; 8:R15.
46. Baumgart DC, Metzke D, Schmitz J etal. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut 2005; 54:228-236.
47. Chen X, Makala LH, Jin Y etal. Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood. Clin Immunol 2008; 129:413-418.
48. Brown KN, Wijewardana V, Liu X, Barratt-Boyes SM. Rapid influx and death of plasmacytoid dendritic cells in lymph nodes mediate depletion in acute simian immunodeficiency virus infection. PLOS Pathog 2009; 5:e1000413.
49. Swiecki M, Wang Y, Vermi W, Gilfillan S, Schreiber RD, Colonna M. Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo. J Exp Med 2011; 208:2367-2374.